Medical Devices: Page 7
-
Deep Dive
How three companies are using foundation models in radiology
Some firms, such as Aidoc, are working directly with the FDA. Others, such as HOPPR, are offering their foundation models for medtech companies to build their own AI tools.
By Elise Reuter • Sept. 16, 2025 -
Deep Dive
Foundation models are medtech’s newest trend. But what are they?
The AI models, which are built on massive datasets and can be adapted to multiple tasks, have become a part of medtech companies’ lexicon in the past few years.
By Elise Reuter • Sept. 15, 2025 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Intuitive da Vinci 5 updates offer feedback during surgery
Three new software features for Intuitive’s most advanced soft tissue surgical robot have received 510(k) clearance from the Food and Drug Administration.
By Susan Kelly • Sept. 15, 2025 -
B. Braun buys True Digital Surgery for microscopy technology
The acquisition gives B. Braun control of a company that provides technology for its Aeos robotic digital microscope.
By Nick Paul Taylor • Sept. 15, 2025 -
AI drives medtech investment in 2025
Medical device companies working with artificial intelligence raised funding and were acquisition targets in recent months.
By Elise Reuter • Sept. 12, 2025 -
Masimo, Philips extend patient monitoring partnership
The multi-year agreement comes two months after Philips renewed a partnership for patient monitoring technologies with Masimo competitor Medtronic.
By Susan Kelly • Sept. 11, 2025 -
Patients call for more medical device user fee funding, FDA staffing
Commenters to the FDA also advocated for safety reforms and for industry funds to be used for post-market monitoring.
By Elise Reuter • Sept. 11, 2025 -
Philips under investigation by Paris Prosecutor’s Office over recalled respiratory devices
The prosecutor’s office opened an investigation in June, with charges including aggravated fraud and failure to report incidents that pose serious health risks.
By Elise Reuter • Sept. 10, 2025 -
Boston Scientific inks $88M Elutia deal to challenge Medtronic
BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.
By Nick Paul Taylor • Updated Sept. 11, 2025 -
Pulse wins IDE approval; Galvanize pulls in $100M
Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.
By Susan Kelly • Sept. 9, 2025 -
Microbot receives 510(k) clearance for endovascular robot
The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular procedures performed in the U.S. each year.
By Nick Paul Taylor • Sept. 9, 2025 -
Ronovo Surgical raises $67M, led by J&J venture arm
Ronovo, a Chinese surgical robotics company, will also team with a J&J subsidiary in Shanghai to sell Ronovo’s soft tissue platform and complementary J&J technologies.
By Susan Kelly • Sept. 8, 2025 -
Senseonics inks deal to bring CGM commercialization back in-house
BTIG analysts said Senseonics is doubling down on its belief an inflection point in patient demand is imminent, but the company will need a large sales force to win market share.
By Nick Paul Taylor • Sept. 8, 2025 -
AI firm Ketryx raises $39M, adds former Medtronic CEO as investor
The company, which helps medtech companies with AI compliance, has raised more than $55 million to date.
By Elise Reuter • Sept. 5, 2025 -
Medtronic trial of Hugo robot in hernia repair hits primary endpoints
The company reported a 100% surgical success rate, beating the pre-specified 85% performance goal to meet the trial’s primary effectiveness endpoint.
By Nick Paul Taylor • Sept. 5, 2025 -
Dexcom to lay off about 350 people
The diabetes technology company said the cuts are part of broader changes to its structure, including eliminating operations roles in San Diego and shifting those positions to Arizona.
By Elise Reuter • Sept. 4, 2025 -
Renal denervation gets strong backing from cardiologists ahead of Medicare coverage decision
Doctors told the Centers for Medicare and Medicaid Services that more patients need access to the procedure, with one calling it the start of a new era in hypertension management.
By Susan Kelly • Sept. 4, 2025 -
Kardium receives FDA OK for pulsed field ablation system
The company raised $250 million in July to expand its manufacturing capabilities and establish multiple teams to support the launch.
By Nick Paul Taylor • Sept. 4, 2025 -
3 medtech takeaways from ESC 2025
Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.
By Susan Kelly • Sept. 3, 2025 -
Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe
Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”
By Nick Paul Taylor • Sept. 3, 2025 -
Medtronic advances Abbott partnership with FDA nod
The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.
By Elise Reuter • Sept. 2, 2025 -
AI devices with no clinical validation tied to more recalls, study finds
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.
By Elise Reuter • Sept. 2, 2025 -
Medtech VC funding on track to hit highest value since 2021: PitchBook
“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.
By Nick Paul Taylor • Sept. 2, 2025 -
J&J removes some Abiomed heart pump controllers from market
Abiomed reported one death associated with a pump driver circuit assembly that does not meet current specifications. The recall affects 69 controllers, a J&J spokesperson said.
By Susan Kelly • Aug. 28, 2025 -
Inspire CFO Rick Buchholz to step down at end of 2025
RBC analysts said their views on the company are unchanged because the departing CFO will see the “Inspire V roll-out efforts through to completion.”
By Nick Paul Taylor • Aug. 28, 2025